Skip Navigation

Exhibit 300 (BY2009) for Food and Drug Administration (FDA) MedWatch Plus

PART ONE


OVERVIEW


1. Date of Submission:
2008-02-04
2. Agency:
009
3. Bureau:
10
4. Name of this Capital Asset:
FDA MedWatch Plus (FY09)
5. Unique Project Identifier:
009-10-01-03-01-0042-00
6. What kind of investment will this be in FY2009?
Planning
7. What was the first budget year this investment was submitted to OMB?
FY2009
8. Provide a brief summary and justification for this investment, including a brief description of how this closes in part or in whole an identified agency performance gap.
The FDA receives more than 600,000 voluntary post-marketing adverse event (AE) reports annually from manufacturers, health care professionals and consumers for all FDA-regulated products. The reports are analyzed by FDA safety evaluators for product risk assessment. Currently, a variety of computer programs enter the AE report into various databases that contain an archive of more than 3 million AE reports. Not all AE reports are submitted electronically, and there are many paper and data entry steps at this time. Reviewers lack the most up-to-date signal detection technology in order to find patterns that could be buried in the massive amount of data being reviewed. The MedWatch Plus Investment will close the current performance gap to create a fully automated system that possesses up-to-date data with seamless integration points facilitating data sharing and more efficient reviews by the safety evaluators. This investment specifically aligns to the eGov PMA initiative. All FDA AE systems are being reviewed and considered for migration to the MedWatch Plus investment. This will allow the Agency to move away from the current environment of numerous disparate systems and position the FDA toward a fully electronic reporting process. As a result, the average unit cost to prepare and process AE reports will be reduced. It will also increase the consistency and timeliness of reports by utilizing standardized data collection processes. Moving towards an efficient fully electronic process, instituting a user-friendly website encouraging voluntary reports, consolidating the databases into a single data warehouse, and developing powerful tools for risk detection aligns the MedWatch Plus investment with the FDA strategic goal of improving patient and consumer safety and also with the DHHS strategic objective of improving health care quality, safety, cost, and value. The MedWatch Plus initiative will institute a single Internet portal with a user-friendly electronic submission capability for all who provide AE and product information to FDA, encouraging the reporting of information in a quality and uniform manner. Behind the portal will be a single agency-wide data warehouse of AE reports instead of various separate databases. This will enable data sharing through the seamless integration of data. FDA safety evaluators will possess the ability to make vital connections to AE data and strengthen risk detection by finding patterns in data.
9. Did the Agency's Executive/Investment Committee approve this request?
yes
9.a. If "yes," what was the date of this approval?
2007-06-26
10. Did the Project Manager review this Exhibit?
yes
11.a. What is the current FAC-P/PM certification level of the project/program manager?
Senior/Expert-level
12. Has the agency developed and/or promoted cost effective, energy-efficient and environmentally sustainable techniques or practices for this project.
yes
12.a. Will this investment include electronic assets (including computers)?
yes
12.b. Is this investment for new construction or major retrofit of a Federal building or facility? (answer applicable to non-IT assets only)
no
13. Does this investment directly support one of the PMA initiatives?
yes
If yes, select the initiatives that apply:
Initiative Name
Expanded E-Government
13.a. Briefly and specifically describe for each selected how this asset directly supports the identified initiative(s)? (e.g. If E-Gov is selected, is it an approved shared service provider or the managing partner?)
This investment supports expanded e-gov by providing the public and industry with a single, web-enabled focal point to report adverse events. Once implemented, this system will triage the reports to the appropriate Center electronically for investigation providing the Agency with an enterprise-wide system for tracking and signal detection of adverse events. Currently, adverse events are collected by each Center, maintained in disparate databases and information exchanged manually.
14. Does this investment support a program assessed using the Program Assessment Rating Tool (PART)?
no
15. Is this investment for information technology?
yes
16. What is the level of the IT Project (per CIO Council's PM Guidance)?
Level 2
17. What project management qualifications does the Project Manager have? (per CIO Council's PM Guidance)
(1) Project manager has been validated as qualified for this investment
18. Is this investment identified as high risk on the Q4 - FY 2007 agency high risk report (per OMB memorandum M-05-23)?
no
19. Is this a financial management system?
no
19.a.2. If no, what does it address?
The FDA receives more than 600,000 post-marketing adverse event reports annually. These reports are analyzed for safety problems and manually routed between Centers. All FDA adverse event systems are being reviewed and considered for migration to the MedWatch Plus investment to provide the Agency with an enterprise-wide system for tracking and signal detection of adverse events in FDA regulated products.
20. What is the percentage breakout for the total FY2009 funding request for the following? (This should total 100%)
AreaPercentage
Hardware0
Software1
Services72
Other27
21. If this project produces information dissemination products for the public, are these products published to the Internet in conformance with OMB Memorandum 05-04 and included in your agency inventory, schedules and priorities?
n/a
22. Contact information of individual responsible for privacy related questions.
NameBrenda Dorsey
Phone Number301-827-6549
TitlePROGRAM SUPPORT SPECIALIST
EmailBrenda.dorsey@fda.hhs.gov
23. Are the records produced by this investment appropriately scheduled with the National Archives and Records Administration's approval?
no
24. Does this investment directly support one of the GAO High Risk Areas?
no

SUMMARY OF SPEND


1. Provide the total estimated life-cycle cost for this investment by completing the following table. All amounts represent budget authority in millions, and are rounded to three decimal places. Federal personnel costs should be included only in the row designated Government FTE Cost, and should be excluded from the amounts shown for Planning, Full Acquisition, and Operation/Maintenance. The total estimated annual cost of the investment is the sum of costs for Planning, Full Acquisition, and Operation/Maintenance. For Federal buildings and facilities, life-cycle costs should include long term energy, environmental, decommissioning, and/or restoration costs. The costs associated with the entire life-cycle of the investment should be included in this report.

All amounts represent Budget Authority

Note: For the cross-agency investments, this table should include all funding (both managing partner and partner agencies).

Government FTE Costs should not be included as part of the TOTAL represented.
Cost TypePy-1 & Earlier
-2006
PY
2007
CY
2008
BY
2009
Planning Budgetary Resources0.0000.3841.9013.298
Acquisition Budgetary Resources0.0001.08711.8935.350
Maintenance Budgetary Resources0.0000.0000.0001.721
Government FTE Cost0.0000.2260.9941.189
# of FTEs0289
2. Will this project require the agency to hire additional FTE's?
no

PERFORMANCE


In order to successfully address this area of the exhibit 300, performance goals must be provided for the agency and be linked to the annual performance plan. The investment must discuss the agency's mission and strategic goals, and performance measures (indicators) must be provided. These goals need to map to the gap in the agency's strategic goals and objectives this investment is designed to fill. They are the internal and external performance benefits this investment is expected to deliver to the agency (e.g., improve efficiency by 60 percent, increase citizen participation by 300 percent a year to achieve an overall citizen participation rate of 75 percent by FY 2xxx, etc.). The goals must be clearly measurable investment outcomes, and if applicable, investment outputs. They do not include the completion date of the module, milestones, or investment, or general goals, such as, significant, better, improved that do not have a quantitative measure.
Agencies must use the following table to report performance goals and measures for the major investment and use the Federal Enterprise Architecture (FEA) Performance Reference Model (PRM). Map all Measurement Indicators to the corresponding Measurement Area and Measurement Grouping identified in the PRM. There should be at least one Measurement Indicator for each of the four different Measurement Areas (for each fiscal year). The PRM is available at www.egov.gov. The table can be extended to include performance measures for years beyond FY 2009.
RowFiscal YearStrategic Goal SupportedMeasurement AreaMeasurement GroupingMeasurement IndicatorBaselinePlanned Improvement to the BaselineActual Results
12008S.O. 1.3 - Improve health care quality, safety, cost and valueTechnologyInteroperabilityPercentage of adverse event reports submitted electronically compared to all adverse event reports - the first step toward fully electronic processing45%55% 
22008S.O. 1.3 - Improve health care quality, safety, cost and valueProcesses and ActivitiesCostsReduce unit cost associated with turning a submitted Adverse Event Report into a verified record in a database   
32008S.O. 1.3 - Improve health care quality, safety, cost and valueMission and Business ResultsPopulation Health Management and Consumer SafetyIncrease in the total number of voluntary reports received for FDA regulated products submitted by subject matter professionals15,10515,558 
42008S.O. 1.3 - Improve health care quality, safety, cost and valueCustomer ResultsCustomer Impact or BurdenPercentage of voluntary reports received over the internet compared to the total number of voluntary reports - this should increase when the user-friendly website is implemented51%53% 
52009S.O. 1.3 - Improve health care quality, safety, cost and valueTechnologyInteroperabilityPercentage of adverse event reports submitted electronically compared to all adverse event reports - the first step toward fully electronic processing55%60% 
62009S.O. 1.3 - Improve health care quality, safety, cost and valueProcesses and ActivitiesCostsReduce unit cost associated with turning a submitted Adverse Event Report into a verified record in a database   
72009S.O. 1.3 - Improve health care quality, safety, cost and valueMission and Business ResultsPopulation Health Management and Consumer SafetyIncrease in the total number of voluntary reports received for FDA regulated products submitted by subject matter professionals15,55816,336 
82009S.O. 1.3 - Improve health care quality, safety, cost and valueCustomer ResultsCustomer Impact or BurdenPercentage of voluntary reports received over the internet compared to the total number of voluntary reports - this should increase when the user-friendly website is implemented53%55% 
92010S.O. 1.3 - Improve health care quality, safety, cost and valueTechnologyInteroperabilityPercentage of adverse event reports submitted electronically compared to all adverse event reports - the first step toward fully electronic processing60%70% 
102010S.O. 1.3 - Improve health care quality, safety, cost and valueProcesses and ActivitiesCostsReduce unit cost associated with turning a submitted Adverse Event Report into a verified record in a database   
112010S.O. 1.3 - Improve health care quality, safety, cost and valueMission and Business ResultsPopulation Health Management and Consumer SafetyIncrease in the total number of voluntary reports received for FDA regulated products submitted by subject matter professionals16,33617,153 
122010S.O. 1.3 - Improve health care quality, safety, cost and valueCustomer ResultsCustomer Impact or BurdenPercentage of voluntary reports received over the internet compared to the total number of voluntary reports - this should increase when the user-friendly website is implemented55%56% 
132011S.O. 1.3 - Improve health care quality, safety, cost and valueTechnologyInteroperabilityPercentage of adverse event reports submitted electronically compared to all adverse event reports - the first step toward fully electronic processing70%77.50% 
142011S.O. 1.3 - Improve health care quality, safety, cost and valueProcesses and ActivitiesCostsReduce unit cost associated with turning a submitted Adverse Event Report into a verified record in a database   
152011S.O. 1.3 - Improve health care quality, safety, cost and valueMission and Business ResultsPopulation Health Management and Consumer SafetyIncrease in the total number of voluntary reports received for FDA regulated products submitted by subject matter professionals17,15318,011 
162011S.O. 1.3 - Improve health care quality, safety, cost and valueCustomer ResultsCustomer Impact or BurdenPercentage of voluntary reports received over the internet compared to the total number of voluntary reports - this should increase when the user-friendly website is implemented56%65% 
172012S.O. 1.3 - Improve health care quality, safety, cost and valueTechnologyInteroperabilityPercentage of adverse event reports submitted electronically compared to all adverse event reports - the first step toward fully electronic processing77.50%80% 
182012S.O. 1.3 - Improve health care quality, safety, cost and valueProcesses and ActivitiesCostsReduce unit cost associated with turning a submitted Adverse Event Report into a verified record in a database   
192012S.O. 1.3 - Improve health care quality, safety, cost and valueMission and Business ResultsPopulation Health Management and Consumer SafetyIncrease in the total number of voluntary reports received for FDA regulated products submitted by subject matter professionals18,01118,551 
202012S.O. 1.3 - Improve health care quality, safety, cost and valueCustomer ResultsCustomer Impact or BurdenPercentage of voluntary reports received over the internet compared to the total number of voluntary reports - this should increase when the user-friendly website is implemented65%66% 
212013S.O. 1.3 - Improve health care quality, safety, cost and valueTechnologyInteroperabilityPercentage of adverse event reports submitted electronically compared to all adverse event reports - the first step toward fully electronic processing80%81% 
222013S.O. 1.3 - Improve health care quality, safety, cost and valueProcesses and ActivitiesCostsReduce unit cost associated with turning a submitted Adverse Event Report into a verified record in a database   
232013S.O. 1.3 - Improve health care quality, safety, cost and valueMission and Business ResultsPopulation Health Management and Consumer SafetyIncrease in the total number of voluntary reports received for FDA regulated products submitted by subject matter professionals18,55119,107 
242013S.O. 1.3 - Improve health care quality, safety, cost and valueCustomer ResultsCustomer Impact or BurdenPercentage of voluntary reports received over the internet compared to the total number of voluntary reports - this should increase when the user-friendly website is implemented66%67% 

Enterprise Architecture


In order to successfully address this area of the business case and capital asset plan you must ensure the investment is included in the agency's EA and Capital Planning and Investment Control (CPIC) process, and is mapped to and supports the FEA. You must also ensure the business case demonstrates the relationship between the investment and the business, performance, data, services, application, and technology layers of the agency's EA.
1. Is this investment included in your agency's target enterprise architecture?
yes
2. Is this investment included in the agency's EA Transition Strategy?
no
2.b. If no, please explain why?
This is a new investment, which did not exist at the time of the last EA Assessment.
3. Is this investment identified in a completed (contains a target architecture) and approved segment architecture?
no
4. Identify the service components funded by this major IT investment (e.g., knowledge management, content management, customer relationship management, etc.). Provide this information in the format of the following table. For detailed guidance regarding components, please refer to http://www.whitehouse.gov/omb/egov/.

Component: Use existing SRM Components or identify as NEW. A NEW component is one not already identified as a service component in the FEA SRM.

Reused Name and UPI: A reused component is one being funded by another investment, but being used by this investment. Rather than answer yes or no, identify the reused service component funded by the other investment and identify the other investment using the Unique Project Identifier (UPI) code from the OMB Ex 300 or Ex 53 submission.

Internal or External Reuse?: Internal reuse is within an agency. For example, one agency within a department is reusing a service component provided by another agency within the same department. External reuse is one agency within a department reusing a service component provided by another agency in another department. A good example of this is an E-Gov initiative service being reused by multiple organizations across the federal government.

Funding Percentage: Please provide the percentage of the BY requested funding amount used for each service component listed in the table. If external, provide the funding level transferred to another agency to pay for the service.
RowAgency Component NameAgency Component DescriptionService TypeComponentReused Component NameReused UPIInternal or External Reuse?Funding %
1Audit Trail Capture and AnalysisAudit Trail Capture and Analysis - Support the identification and monitoring of activities within an application, system, or network.Security ManagementAudit Trail Capture and Analysis  No Reuse3
2Identification and AuthenticationDefines the set of capabilities that support obtaining information about those parties attempting to log on to a system or application for security purposes and the validation of those users.Security ManagementIdentification and Authentication  No Reuse3
3Access ControlAccess Control - Support the management of permissions for logging onto a computer, application, service, or network; includes user management and role/privilege management.Security ManagementAccess Control  No Reuse3
4Precision / Recall RankingDefines the set of capabilities that support selection and retrieval of records ranked to optimize precision against recall.SearchPrecision / Recall Ranking  No Reuse3
5Pattern MatchingDefines the set of capabilities that support retrieval of records generated from a data source by imputing characteristics based on patterns in the content or context.SearchPattern Matching  No Reuse3
6QueryDefines the set of capabilities that support retrieval of records that satisfy specific query selection criteria.SearchQuery  No Reuse3
7ClassificationDefines the set of capabilities that support selection and retrieval of records organized by shared characteristics in content or context.SearchClassification  No Reuse3
8Document LibraryDefines the set of capabilities that support the grouping and archiving of files and records on a server.CollaborationDocument Library  No Reuse3
9Document ConversionDefines the set of capabilities that support the changing of files from one type of format to another.Document ManagementDocument Conversion  No Reuse3
10Document Imaging and OCRDefines the set of capabilities that support the scanning of documents.Document ManagementDocument Imaging and OCR  No Reuse3
11IndexingDefines the set of capabilities that support the rapid retrieval of documents through a structured numbering construct.Document ManagementIndexing  No Reuse3
12Library / StorageDefines the set of capabilities that support document and data warehousing and archiving.Document ManagementLibrary / Storage  No Reuse3
13Document Review and ApprovalDefines the set of capabilities that support the editing and commendation of documents before releasing them.Document ManagementDocument Review and Approval  No Reuse3
14Document RevisionsDefines the set of capabilities that support the versioning and editing of content and documents.Document ManagementDocument Revisions  No Reuse3
15Content AuthoringDefines the capabilities that allow for the creation of tutorials, CBT courseware, web sites, CD-ROMs and other interactive programs.Content ManagementContent Authoring  No Reuse3
16Content Review and ApprovalDefines the capabilities that allow for the approval of interactive programs.Content ManagementContent Review and Approval  No Reuse3
17CategorizationDefines the set of capabilities that allow classification of data and information into specific layers or types to support an organization.Knowledge ManagementCategorization  No Reuse3
18Information SharingDefines the set of capabilities that support the use of documents and data in a multi-user environment for use by an organization and its stakeholders.Knowledge ManagementInformation Sharing  No Reuse3
19Information RetrievalDefines the set of capabilities that allow access to data and information for use by an organization and its stakeholders.Knowledge ManagementInformation Retrieval  No Reuse3
20Standardized / CannedDefines the set of capabilities that support the use of pre-conceived or pre-written reports.ReportingStandardized / Canned  No Reuse3
21Ad HocDefines the set of capabilities that support the use of dynamic reports on an as needed basis.ReportingAd Hoc  No Reuse3
22ImageryDefines the set of capabilities that support the creation of film or electronic images from pictures or paper formsVisualizationImagery  No Reuse3
23Data ClassificationDefines the set of capabilities that allow the classification of data.Data ManagementData Classification  No Reuse3
24Data CleansingDefines the set of capabilities that support the removal of incorrect or unnecessary characters and data from a data source.Data ManagementData Cleansing  No Reuse3
25Extraction and TransformationDefines the set of capabilities that support the manipulation and change of data.Data ManagementExtraction and Transformation  No Reuse3
26Loading and ArchivingDefines the set of capabilities that support the population of a data source with external data.Data ManagementLoading and Archiving  No Reuse3
27Data ExchangeDefines the set of capabilities that support the interchange of information between multiple systems or applications; includes verification that transmitted data was received unaltered.Data ManagementData Exchange  No Reuse3
28Legacy IntegrationDefines the set of capabilities that support the communication between newer generation hardware/software applications and the previous, major generation of hardware/software applications.Development and IntegrationLegacy Integration  No Reuse3
29Data IntegrationDefines the set of capabilities that support the organization of data from separate data sources into a single source using middleware or application integration and the modification of system data models to capture new information within a single system.Development and IntegrationData Integration  No Reuse3
30Business Rule ManagementDefines the set of capabilities that manage the enterprise processes that support an organization and its policies.Management of ProcessesBusiness Rule Management  No Reuse3
31Governance / Policy ManagementDefines the set of capabilities that influence and determine decisions, actions, business rules and other matters within an organization.Management of ProcessesGovernance / Policy Management  No Reuse3
32Configuration ManagementDefines the set of capabilities that control the hardware and software environments, as well as documents of an organization.Management of ProcessesConfiguration Management  No Reuse3
33Alerts and NotificationsDefines the set of capabilities that allow a customer to be contacted in relation to a subscription or service of interest.Customer PreferencesAlerts and Notifications  No Reuse3
34Online HelpDefines the set of capabilities that provide an electronic interface to customer assistance.Customer Initiated AssistanceOnline Help  No Reuse3
35Certification and AccreditationCertification and Accreditation - Supports the certification and accreditation (C&A) of federal information systems, as described in NIST SP800-37.Security ManagementCertification and Accreditation  No Reuse3
36Intrusion PreventionIntrusion Prevention - Includes penetration testing and other measures to prevent unauthorized access to a government information system.Security ManagementIntrusion Prevention  No Reuse3
5. To demonstrate how this major IT investment aligns with the FEA Technical Reference Model (TRM), please list the Service Areas, Categories, Standards, and Service Specifications supporting this IT investment.

FEA SRM Component: Service Components identified in the previous question should be entered in this column. Please enter multiple rows for FEA SRM Components supported by multiple TRM Service Specifications.

Service Specification: In the Service Specification field, Agencies should provide information on the specified technical standard or vendor product mapped to the FEA TRM Service Standard, including model or version numbers, as appropriate.
RowSRM Component>Service AreaService CategoryService StandardService Specification (i.e., vendor and product name)
1Audit Trail Capture and AnalysisService Platform and InfrastructureSoftware EngineeringSoftware Configuration ManagementTBD
2Identification and AuthenticationComponent FrameworkSecurityCertificates / Digital SignaturesTBD
3Access ControlService Access and DeliveryService RequirementsAuthentication / Single Sign-onTBD
4Precision / Recall RankingService Platform and InfrastructureInteroperabilityData Format / ClassificationTBD
5Pattern MatchingService Platform and InfrastructureInteroperabilityData Format / ClassificationTBD
6QueryService Platform and InfrastructureInteroperabilityData Format / ClassificationTBD
7ClassificationService Platform and InfrastructureInteroperabilityData Format / ClassificationTBD
8Document LibraryService Platform and InfrastructureDatabase / StorageDatabaseTBD
9Document ConversionService Interface and IntegrationInteroperabilityData TransformationTBD
10Document Imaging and OCRComponent FrameworkData ManagementDatabase ConnectivityTBD
11IndexingService Platform and InfrastructureInteroperabilityData Format / ClassificationTBD
12Library / StorageService Platform and InfrastructureDatabase / StorageDatabaseTBD
13Document Review and ApprovalComponent FrameworkData ManagementReporting and AnalysisTBD
14Document RevisionsComponent FrameworkData InterchangeData ExchangeTBD
15Content AuthoringService Interface and IntegrationInteroperabilityData Format / ClassificationTBD
16Content Review and ApprovalComponent FrameworkPresentation / InterfaceContent RenderingTBD
17CategorizationService Interface and IntegrationInteroperabilityData Format / ClassificationTBD
18Information SharingComponent FrameworkPresentation / InterfaceContent RenderingTBD
19Information RetrievalService Platform and InfrastructureInteroperabilityData Format / ClassificationTBD
20Standardized / CannedComponent FrameworkData ManagementReporting and AnalysisTBD
21Ad HocComponent FrameworkData ManagementReporting and AnalysisTBD
22ImageryComponent FrameworkData ManagementReporting and AnalysisTBD
23Data ClassificationService Platform and InfrastructureInteroperabilityData Format / ClassificationTBD
24Data CleansingService Platform and InfrastructureInteroperabilityData TransformationTBD
25Extraction and TransformationService Platform and InfrastructureInteroperabilityData TransformationTBD
26Loading and ArchivingService Platform and InfrastructureDatabase / StorageDatabaseTBD
27Data ExchangeService Access and DeliveryService TransportService TransportTBD
28Legacy IntegrationService Platform and InfrastructureDelivery ServersApplication ServersTBD
29Data IntegrationComponent FrameworkData ManagementReporting and AnalysisTBD
30Business Rule ManagementService Platform and InfrastructureInteroperabilityData Format / ClassificationTBD
31Governance / Policy ManagementService Platform and InfrastructureInteroperabilityData Format / ClassificationTBD
32Configuration ManagementService Platform and InfrastructureSoftware EngineeringSoftware Configuration ManagementTBD
33Alerts and NotificationsComponent FrameworkData InterchangeData ExchangeTBD
34Online HelpComponent FrameworkPresentation / InterfaceContent RenderingTBD
35Certification and AccreditationComponent FrameworkSecuritySupporting Security ServicesTBD
36Intrusion PreventionComponent FrameworkData ManagementReporting and AnalysisTBD
6. Will the application leverage existing components and/or applications across the Government (i.e., FirstGov, Pay.Gov, etc)?
yes
6.a. If yes, please describe.
The MedWatch Plus initiative will initially utilize adverse event reporting systems from three FDA Centers (CDER, CBER & CDRH). As planning continues, assessments will be made as to further identify and leverage other applications across the agency.

PART TWO


RISK


You should perform a risk assessment during the early planning and initial concept phase of the investment's life-cycle, develop a risk-adjusted life-cycle cost estimate and a plan to eliminate, mitigate or manage risk, and be actively managing risk throughout the investment's life-cycle.

Answer the following questions to describe how you are managing investment risks.
1. Does the investment have a Risk Management Plan?
yes
1.a. If yes, what is the date of the plan?
2007-08-09
1.b. Has the Risk Management Plan been significantly changed since last year's submission to OMB?
no
3. Briefly describe how investment risks are reflected in the life cycle cost estimate and investment schedule:
The lifecycle costs for this investment are risk-adjusted and the investment schedule has been developed in incremental phases with built in stage-gate reviews to provide opportunities to adjust the schedule accordingly and rebaseline based on previous development increments.

COST & SCHEDULE


1. Does the earned value management system meet the criteria in ANSI/EIA Standard 748?
yes
2. Is the CV% or SV% greater than ± 10%?
no
3. Has the investment re-baselined during the past fiscal year?
no